Department of Health and Ageing [2006] AUSStaCSDLM 215 (1 December 2006)

• DEPARTMENT OF HEALTH AND AGEING

---

DEPARTMENT OF HEALTH AND AGEING

Amendment Determination No. 3 under paragraph 98B(1)(a) of the National Health Act 1953 [F2006L03873]
National Health Act 1953
Made	24/11/2006
Tabled	30/11/2006 S	29/11/2006 HR
Summary	Amends the Principal Determination to reflect changes to references to certain legislative instruments.

Chemotherapy Pharmaceuticals Access Program — Arrangements made under subparagraph 100(1)(b)(i) of the National Health Act 1953 (No. PB 52 of 2006) [F2006L03692]
National Health Act 1953
Made	07/11/2006
Tabled	27/11/2006 S	27/11/2006 HR
Summary	Amends the arrangements for the availability of chemotherapy pharmaceuticals at public hospitals to non-admitted patients, day admitted patients or patients on discharge.

Declaration No. PB 46 of 2006 under s. 85(2) of the National Health Act 1953 [F2006L03668]
National Health Act 1953
Made	07/11/2006
Tabled	27/11/2006 S	27/11/2006 HR
Summary	Specifies a revised list of drugs and medicinal preparations that are available as pharmaceutical benefits.

Declaration No. PB 49 of 2006 under s. 85(2AA) of the National Health Act 1953 [F2006L03688]
National Health Act 1953
Made	07/11/2006
Tabled	27/11/2006 S	27/11/2006 HR
Summary	Specifies certain drugs and medicinal preparations that are no longer available as pharmaceutical benefits.

Determination No. PB 47 of 2006 under ss. 85, 85A and 88 of the National Health Act 1953 [F2006L03686]
National Health Act 1953
Made	07/11/2006
Tabled	27/11/2006 S	27/11/2006 HR
Summary	Specifies a revised list of drugs and medicinal preparations that are available as pharmaceutical benefits.

Determination No. PB 48 of 2006 under s. 85B(1) of the National Health Act 1953 [F2006L03687]
National Health Act 1953
Made	07/11/2006
Tabled	27/11/2006 S	27/11/2006 HR
Summary	Specifies a revised list of drugs and medicinal preparations that are available as pharmaceutical benefits.

Determination No. PB 50 of 2006 under paragraph 98C(1)(b) of the National Health Act 1953 [F2006L03689]
National Health Act 1953
Made	07/11/2006
Tabled	27/11/2006 S	27/11/2006 HR
Summary	Specifies a revised list of drugs and medicinal preparations that are available as pharmaceutical benefits.

Determination that Dealings with Genetically Modified Carnation Lines be Included on the GMO Register under s. 78 of the Gene Technology Act 2000 [F2006L03771]
Gene Technology Act 2000
Made	27/11/2006
Tabled	30/11/2006 S	29/11/2006 HR
Summary	Provides that specified dealings with genetically modified carnations be included on the GMO Register.

Health Insurance (Diagnostic Imaging Services Table) Amendment Regulations 2006 (No. 5) Select Legislative Instrument 2006 No. 303 [F2006L03520]
Health Insurance Act 1973
Made	16/11/2006
Tabled	27/11/2006 S	27/11/2006 HR
Summary	Permit Medicare benefits to be paid for certain magnetic resonance imaging services conducted at specified locations.

Highly Specialised Drugs Program — Arrangements made under subparagraph 100(1)(b)(i) of the National Health Act 1953 (No. PB 51 of 2006) [F2006L03690]
National Health Act 1953
Made	07/11/2006
Tabled	27/11/2006 S	27/11/2006 HR
Summary	Amends the arrangements for the availability of special pharmaceutical products for persons who are receiving treatment with highly specialised drugs at private hospitals to non-admitted patients, day admitted patients or patients on discharge.

Special Authority Program (Imatinib Mesylate) — Arrangements made under subparagraph 100(1)(b)(i) of the National Health Act 1953 (No. PB 53 of 2006) [F2006L03693]
National Health Act 1953
Made	07/11/2006
Tabled	27/11/2006 S	27/11/2006 HR
Summary	Amends the arrangements for the availability of special pharmaceutical products to persons who require treatment with imatinib mesylate.

Special Authority Program (Trastuzumab) — Arrangements made under subparagraph 100 (1)(b)(i) of the National Health Act 1953 (No. PB 54 of 2006) [F2006L03696]
National Health Act 1953
Made	07/11/2006
Tabled	27/11/2006 S	27/11/2006 HR
Summary	Amends the arrangements for the availability of special pharmaceutical products to persons who require treatment with trastuzumab.